Skip to Content
UW Health SMPH
American Family Children's Hospital
Michael D. Carrithers, MD, PhD close
Michael D. Carrithers, MD, PhD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Michael D. Carrithers, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Carrithers is an associate professor of neurology at the University of Wisconsin School of Medicine and Public Health and is affiliated with the University of Wisconsin Hospital and Clinics and the William S. Middleton Veterans Hospital. He is board-certified in psychiatry and neurology and is a member of the American Academy of Neurology, American Association for the Advancement of Science and Society for Neuroscience. Dr. Carrithers completed his neurology residency and postdoctoral fellowship in immunobiology and neurology at Yale University. His clinical focus is multiple sclerosis.



UW Health Clinics

UW Hospital and Clinics
(608) 262-0546 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

UW School of Medicine and Public Health

Department of Neurology

Professional Certifications and Education

Board Certification Neurology
Fellowship Yale New Haven Hospital, New Haven, CT
Residency Yale New Haven Hospital, New Haven, CT
Medical School University of Illinois College of Medicine, Chicago, IL, 1992

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Programs & Conditions


Dr. Carrithers' basic science research in multiple sclerosis and neuroimmunology focuses on immune surveillance of the brain and human macrophage function in health and disease. The goal of his translational and clinical research program is to identify functional cellular markers of disease activity in multiple sclerosis patients and develop novel targets for immune therapy.

PubMed Articles
Jones A Kainz D Khan F Lee C Carrithers MD . Human macrophage SCN5A activates an innate immune signaling pathway for antiviral host defense. J Biol Chem. 2014 Dec 19;289(51):35326-40
[PubMed ID: 25368329]
Carrithers MD . Update on disease-modifying treatments for multiple sclerosis. Clin Ther. 2014 Dec 1;36(12):1938-45
[PubMed ID: 25218310]
Carrithers MD . Innate immune viral recognition: relevance to CNS infections. Handb Clin Neurol. 2014;123:215-23
[PubMed ID: 25015487]
Rahgozar K Wright E Carrithers LM Carrithers MD . Mediation of protection and recovery from experimental autoimmune encephalomyelitis by macrophages expressing the human voltage-gated sodium channel NaV1.5. J Neuropathol Exp Neurol. 2013 Jun;72(6):489-504
[PubMed ID: 23656992]
Wright E Rahgozar K Hallworth N Lanker S Carrithers MD . Epithelial V-like antigen mediates efficacy of anti-alphaâ‚„ integrin treatment in a mouse model of multiple sclerosis. PLoS One. 2013;8(8):e70954
[PubMed ID: 23951051]
Carrithers MD . Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repair. Curr Pharm Biotechnol. 2012 Jun;13(8):1409-17
[PubMed ID: 22339217]
Carrithers MD . Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-mediated Repair. Curr Pharm Biotechnol. 2012 Feb 14;
[PubMed ID: 22339218]
Carrithers LM Hulseberg P Sandor M Carrithers MD . The human macrophage sodium channel NaV1.5 regulates mycobacteria processing through organelle polarization and localized calcium oscillations. FEMS Immunol Med Microbiol. 2011 Dec;63(3):319-27
[PubMed ID: 22092558]
Wojcik E Carrithers LM Carrithers MD . Characterization of epithelial V-like antigen in human choroid plexus epithelial cells: potential role in CNS immune surveillance. Neurosci Lett. 2011 May 16;495(2):115-20
[PubMed ID: 21440040]